Fundz

Hera Biotech Closes Oversubscribed $1.9 Million Seed Raise For Novel Diagnostic Test For Endometriosis

PRIVATEAug 24, 2022

Amount Raised

$1.9 Million

Round Type

Seed

San AntonioBiotechnologyHealth Careresearch

Description

San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing round to support the company’s commercialization strategy for its category-defining non-surgical diagnostic test for endometriosis, MetriDxTM. The funds will be used to complete an in-patient human clinical study, expand Hera’s IP portfolio, and support a regulatory pathway with the US FDA.

Quick answer

Hera Biotech raised $1.9 Million in a Seed round, dated August 24, 2022. Hera Biotech is based in San Antonio, Texas, United States.

How much did Hera Biotech raise?
Hera Biotech raised $1.9 Million in a Seed round on August 24, 2022.
What does Hera Biotech do?
Hera Biotech is a women’s health company dedicated to advancing the standard of care by addressing critical diagnostic and therapeutic deficiencies.
Where is Hera Biotech based and how big is it?
Hera Biotech is based in San Antonio, Texas, United States. Fundz records about 8 employees.
Who are the decision-makers at Hera Biotech?
Fundz holds 1 contact at Hera Biotech, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Hera Biotech, and when

A new round usually means Hera Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hera Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hera Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hera Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hera Biotech

Location

4725 COLLEGE PARK, SUITE 200

San Antonio, Texas, United States

About

Hera Biotech is a women’s health company dedicated to advancing the standard of care by addressing critical diagnostic and therapeutic deficiencies. With a vision to become the global leader in women’s health innovation, Hera’s first mission is to validate and commercialize the world’s first non-surgical method for diagnosing and staging endometriosis, transforming how this condition is detected and managed.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hera Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPaul C., Executive Officer, Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Hera Biotech's next move

See what Strategic adds

Hera Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.